| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them |
| 01/14/1999 | WO1999001551A2 Novel inhibitor of cellular proliferation |
| 01/14/1999 | WO1999001542A1 IKK-β PROTEINS, NUCLEIC ACIDS AND METHODS |
| 01/14/1999 | WO1999001541A1 IKK-α PROTEINS, NUCLEIC ACIDS AND METHODS |
| 01/14/1999 | WO1999001472A1 Cyclic azapeptides with angiogenic effect |
| 01/14/1999 | WO1999001471A1 Nik proteins, nucleic acids and methods |
| 01/14/1999 | WO1999001470A2 Peptidomimetic derivatives suicidal inhibitors of the hiv proliferation |
| 01/14/1999 | WO1999001466A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1999001465A1 A senescence gene and its use in the treatment of cancer and other diseases |
| 01/14/1999 | WO1999001464A1 Componds and methods for treating and screening viral reactivation |
| 01/14/1999 | WO1999001463A2 Modified glycosides, compositions comprised thereof and methods of use thereof |
| 01/14/1999 | WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | WO1999001163A1 Cloning using donor nuclei from non-serum starved, differentiated cells |
| 01/14/1999 | WO1999001158A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 01/14/1999 | WO1999001155A1 Brain-protective agent |
| 01/14/1999 | WO1999001152A1 Methods for inactivating enveloped rna virus particles and compositions for use therewith |
| 01/14/1999 | WO1999001151A1 Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity |
| 01/14/1999 | WO1999001150A1 Novel composition for treating, preventing and/or delaying ischemic cell death |
| 01/14/1999 | WO1999001147A1 Method and product using sturgeon notochord for alleviating the symptoms of arthritis |
| 01/14/1999 | WO1999001146A1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 01/14/1999 | WO1999001145A1 Human mesenchymal stem cells from peripheral blood |
| 01/14/1999 | WO1999001139A1 An improved method for design and selection of efficacious antisense oligonucleotides |
| 01/14/1999 | WO1999001118A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 01/14/1999 | WO1999001103A2 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 01/14/1999 | WO1999001031A1 Methods for screening agents for inhibiting virulence in candida albicans using tup1 sequences |
| 01/14/1999 | WO1999001020A2 19 human secreted proteins |
| 01/14/1999 | WO1998050431A3 A method for making multispecific antibodies having heteromultimeric and common components |
| 01/14/1999 | WO1998044102A3 Methods of modulating p33ing1 mediated apoptosis |
| 01/14/1999 | WO1998044096A3 Mycobacterium recombinant vaccines |
| 01/14/1999 | WO1998040498A3 Immunoadhesins and methods of production and use thereof |
| 01/14/1999 | WO1998039436A3 Fibroblast growth factor mutein compositions and methods of use therefor |
| 01/14/1999 | WO1998039421A3 Mammalian proteinases; oxidoreductases; gtp binding proteins; related reagents |
| 01/14/1999 | WO1998039029A3 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction |
| 01/14/1999 | WO1998038212A3 Chimeric polypeptides containing chemokine domains |
| 01/14/1999 | WO1998036067A3 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1998035040A3 A single gene encoding aortic-specific and striated-specific muscle cell isoforms and uses thereof |
| 01/14/1999 | WO1998035020A3 Methods for modulating hematopoiesis and vascular growth |
| 01/14/1999 | WO1998034952A3 Il-2 gene expression and delivery systems and uses |
| 01/14/1999 | WO1998021333A3 Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
| 01/14/1999 | DE19745666A1 Use of antisense oligonucleotide against ICAM-1 |
| 01/14/1999 | DE19729810A1 Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung Means for sepsis therapy, its preparation and its use |
| 01/14/1999 | DE19729544A1 Ancrod spezifische monoklonale Antikörper, Antikörperfragmente, deren Mischung oder Derivate und deren Verwendung Ancrod specific monoclonal antibodies, antibody fragments, their mixture or their derivatives and the use thereof |
| 01/14/1999 | CA2297181A1 Cyclic azapeptides |
| 01/14/1999 | CA2296105A1 Novel inhibitor of cellular proliferation |
| 01/14/1999 | CA2295933A1 Compounds and methods for treating and screening viral reactivation |
| 01/14/1999 | CA2295294A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | CA2295212A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | CA2294944A1 Human mesenchymal stem cells from peripheral blood |
| 01/14/1999 | CA2294916A1 Cloning using donor nuclei from non-serum starved, differentiated cells |
| 01/14/1999 | CA2294824A1 Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity |
| 01/14/1999 | CA2294793A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 01/14/1999 | CA2294782A1 Vertebrate telomerase genes and proteins and uses thereof |
| 01/14/1999 | CA2294705A1 19 human secreted proteins |
| 01/14/1999 | CA2294702A1 Mammalian secretory peptide-9 |
| 01/14/1999 | CA2289453A1 Screening methods using an atpase protein from a virus of the flaviviridae family |
| 01/14/1999 | CA2264792A1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 01/14/1999 | CA2242559A1 Agents for the prevention and/or treatment of radiation-induced disorders |
| 01/14/1999 | CA2236489A1 Novel compounds |
| 01/14/1999 | CA2225187A1 Xaf genes and polypeptides: methods and reagents for modulating apoptosis |
| 01/13/1999 | EP0890647A2 PcrA, novel polypeptide of the DNA helicases family |
| 01/13/1999 | EP0890644A2 MurA gene from Staphylococcus aureus encoding DP-N-Acetylglucosamine enolpyruvyl transferase |
| 01/13/1999 | EP0890643A2 25-Hydroxyvitamin D3-1a-hydroxylase and dna encoding the hydroxylase |
| 01/13/1999 | EP0890641A1 Novel IspA |
| 01/13/1999 | EP0890640A2 G-CSF analog compositions and methods |
| 01/13/1999 | EP0890639A2 BMP2-induced cDNA and its use |
| 01/13/1999 | EP0890638A2 Cancerous metastasis inhibitor |
| 01/13/1999 | EP0890361A1 Antitumor agent |
| 01/13/1999 | EP0890105A1 Methods for diagnosing and treating alzheimer's disease |
| 01/13/1999 | EP0890101A1 Selectively n-alkylated peptidomimetic combinatorial libraries and compounds therein |
| 01/13/1999 | EP0889972A1 Diagnostic method and apparatus |
| 01/13/1999 | EP0889964A1 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 01/13/1999 | EP0889961A2 Monocyte chemotactic protein-5 materials and methods |
| 01/13/1999 | EP0889955A1 Recombinant phages |
| 01/13/1999 | EP0889954A1 Treatment of antigen presenting cells to modulate antigen presenting cell function |
| 01/13/1999 | EP0889906A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 01/13/1999 | EP0889905A1 Cytokine antagonists and agonists |
| 01/13/1999 | EP0889903A1 Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use |
| 01/13/1999 | EP0889902A1 Antibiotic peptides from bovine milk |
| 01/13/1999 | EP0889901A1 Process and intermediates for the synthesis of lhrh antagonists |
| 01/13/1999 | EP0889900A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 01/13/1999 | EP0889899A1 Mycoplasma arthritidis superantigen |
| 01/13/1999 | EP0889880A1 Eprosartan dihydrate and a process for its production and formulation |
| 01/13/1999 | EP0889737A1 Obesity protein compounds and formulations thereof |
| 01/13/1999 | EP0889735A1 Immunological methods for the treatment of gastrointestinal cancer |
| 01/13/1999 | EP0889733A1 Stabilised growth hormone formulation and method of preparation thereof |
| 01/13/1999 | EP0889732A1 Macrophage stimulating protein for the treatment of gastrointestinal disorders |
| 01/13/1999 | EP0889731A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 01/13/1999 | EP0889730A1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 01/13/1999 | EP0847278A4 Analogs of parathyroid hormone |
| 01/13/1999 | EP0804202A4 Estrogens and parathyroid hormone for treating osteoporosis |
| 01/13/1999 | EP0750664A4 Reproduction and utilization of functional human tissue |
| 01/13/1999 | EP0731787B1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine |
| 01/13/1999 | EP0724598B1 Growth factor heterodimers |
| 01/13/1999 | EP0671910A4 Glaucoma treatment. |
| 01/13/1999 | CN1205012A Urogenital carcinoma TLP complex peptides and antibodies thereof |
| 01/13/1999 | CN1204962A Synergistic immunosuppressant composition containing 2,2'-Bi-1H-pyrrole compound |
| 01/13/1999 | CN1204651A Preparation method for spirulina polypeptide and medicament containing these polypeptide and application |
| 01/13/1999 | CN1041634C Oxytocin antagonist and compound and use thereof |
| 01/12/1999 | US5859353 Corn Inbred lines for dairy cattle feed |
| 01/12/1999 | US5859252 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |